Celanese (CE)
(Delayed Data from NYSE)
$136.90 USD
+0.77 (0.57%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $136.96 +0.06 (0.04%) 7:58 PM ET
4-Sell of 5 4
B Value F Growth F Momentum D VGM
Celanese (CE) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$161.44 | $184.00 | $130.00 | 18.59% |
Price Target
Based on short-term price targets offered by 18 analysts, the average price target for Celanese comes to $161.44. The forecasts range from a low of $130.00 to a high of $184.00. The average price target represents an increase of 18.59% from the last closing price of $136.13.
Analyst Price Targets (18)
Broker Rating
Celanese currently has an average brokerage recommendation (ABR) of 2.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 18 brokerage firms. The current ABR compares to an ABR of 2.67 a month ago based on 18 recommendations.
Of the 18 recommendations deriving the current ABR, five are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 27.78% and 5.56% of all recommendations. A month ago, Strong Buy made up 27.78%, while Buy represented 5.56%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/CE.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 9 | 9 | 9 | 10 | 9 |
Sell | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 2 | 2 | 2 | 2 | 2 |
ABR | 2.67 | 2.67 | 2.67 | 2.68 | 2.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/9/2024 | BMO Capital Markets | John P Mcnulty | Hold | Hold |
6/28/2024 | Tudor Pickering Holt & Co. | Matthew Blair | Strong Sell | Strong Sell |
6/27/2024 | Wells Fargo Securities | Michael J Sison | Strong Buy | Strong Buy |
5/17/2024 | Piper Sandler | Charles N Neivert | Strong Buy | Strong Buy |
5/16/2024 | Evercore Partners | Stephen Richardson | Not Available | Hold |
5/10/2024 | Robert W. Baird & Co. | Ghansham Panjabi | Strong Buy | Strong Buy |
5/8/2024 | Mizuho SecuritiesUSA | John Roberts | Hold | Hold |
4/19/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
4/10/2024 | Not Identified | Not Identified | Hold | Hold |
4/9/2024 | KeyBanc Capital Markets | Aleksey Yefremov | Strong Buy | Strong Buy |
4/4/2024 | Not Identified | Not Identified | Strong Buy | Hold |
3/15/2024 | Vertical Research Partners | Kevin W Mccarthy | Hold | Hold |
12/14/2023 | UBS | Joshua Spector | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.67 |
ABR (Last week) | 2.67 |
# of Recs in ABR | 18 |
Average Target Price | $161.44 |
LT Growth Rate | 20.60% |
Industry | Chemical - Specialty |
Industry Rank by ABR | 72 of 252 |
Current Quarter EPS Est: | 2.80 |